Depósito Digital de Documentos de la UAB Encontrados 10 registros  La búsqueda tardó 0.00 segundos. 
1.
7 p, 283.2 KB A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features : results from psoriasis patients in Spain / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; van de Kerkhof, P. C. M. (Radboud University Nijmegen Medical Centre) ; Reich, K. (Sclderm Research Institute and Dermatologikum Hamburg) ; Bachelez, Hervé (Sorbonne Paris Cité Université Paris Diderot) ; Barker, J.N (King's College London) ; Girolomoni, G. (University of Verona) ; Paul, C. (Paul Sabatier University and Larrey Hospital) ; Universitat Autònoma de Barcelona
The Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey data were not analysed to account for cultural and healthcare system differences across European countries (EC). To utilize MAPP data to characterize psoriasis in Spanish patients, including severity assessment and Dermatology Life Quality Index (DLQI). [...]
2017 - 10.1111/jdv.14195
Journal of the European Academy of Dermatology and Venereology, Vol. 31 Núm. 7 (july 2017) , p. 1176-1182  
2.
9 p, 1.1 MB The biological basis of disease recurrence in psoriasis : a historical perspective and current models / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Costanzo, Antonio (Humanitas University) ; Muñoz-Elías, Ernesto J. (Janssen Research & Development) ; Jazra, Maria (Medical Affairs) ; Wegner, Sven (Janssen-Cilag GmbH) ; Paul, Carle F. (Hôpital Larrey) ; Conrad, Curdin (University Hospital CHUV) ; Universitat Autònoma de Barcelona
A key challenge in psoriasis therapy is the tendency for lesions to recur in previously affected anatomical locations after treatment discontinuation following lesion resolution. Available evidence supports the concept of a localized immunological 'memory' that persists in resolved skin after complete disappearance of visible inflammation, as well as the role of a specific subpopulation of T cells characterized by the dermotropic CCR4 phenotype and forming a local memory. [...]
2022 - 10.1111/bjd.20963
British journal of dermatology, Vol. 186 Núm. 5 (may 2022) , p. 773-781  
3.
9 p, 227.8 KB Prevalence of most common skin diseases in Europe : a population-based study / Richard, M.A. (University Hospital Timone) ; Paul, C. (Université de Toulouse et CHU) ; Nijsten, T. (Erasmus MC) ; Gisondi, Paolo (University of Verona) ; Salavastru, C. (Colentina Clinical Hospital) ; Taieb, C. (EMMA) ; Trakatelli, M. (Papageorgiou Hospital) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Stratigos, A. (National and Kapodistrian University of Athens) ; Universitat Autònoma de Barcelona
The assessment of the prevalence of diseases is of primary importance in planning health policies. No complete data on the prevalence of skin diseases across European countries are available. Objective: To estimate the prevalence of the most frequent skin conditions or diseases in 27 European countries (24 EU countries, plus Norway, Switzerland, and the United Kingdom). [...]
2022 - 10.1111/jdv.18050
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 7 (july 2022) , p. 1088-1096  
4.
14 p, 695.4 KB Comparative effectiveness of biologics in clinical practice : week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO) / Pinter, Andreas (University Hospital of Frankfurt (Alemanya)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Schäkel, Knut (Heidelberg University Hospital (Alemanya)) ; Reich, Adam (Institute of Medical Sciences. Medical College of Rzeszow University) ; Zaheri, Shirin (Imperial College Healthcare NHS Trust) ; Costanzo, Antonio (Humanitas Research Hospital Pieve Emanuele (Milà, Itàlia)) ; Tsai, Tsen-Fang (National Taiwan University Hospital and National Taiwan University College of Medicine) ; Smith, Saxon Donald (Australian National University,College of Health and Medicine) ; Lynde, Charles W. (University of Toronto) ; Brnabic, Alan (Eli Lilly and Company) ; Reed, Catherine L. (Eli Lilly and Company) ; Hill, Julie (Eli Lilly and Company) ; Schuster, Christopher F. (Medical University of Vienna) ; Riedl, Elisabeth (Medical University of Vienna) ; Paul, Carle (Paul Sabatier University and Larrey Hospital (Toulose, França)) ; Universitat Autònoma de Barcelona
Background: Clinical trials study treatment outcomes under stringent conditions, capturing incompletely the heterogeneity of patient populations and treatment complexities encountered in real-world practice. [...]
2022 - 10.1111/jdv.18376
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 11 (november 2022) , p. 2087-2100  
5.
8 p, 294.7 KB Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3 / Warren, R. B. (Dermatology Centre. The University of Manchester. Salford Royal NHS Foundation Trust. NIHR Manchester BRC Centre) ; Hansen, Jes Birger (LEO Pharma) ; Reich, K. (Institute for Health Services Research in Dermatology and Nursing. University Medical Center Hamburg-Eppendorf. Skinflammation® Center) ; Paul, C. (Toulouse University and Larrey Hospital) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Background: Modern biologics achieve complete skin clearance [100% improvement in psoriasis area and severity index (PASI 100)] in 30-45% of psoriasis patients. Cumulative benefit considering rapidity, frequency and sustainability of response has not been thoroughly investigated. [...]
2021 - 10.1111/jdv.16816
Journal of the European Academy of Dermatology and Venereology, Vol. 35 Núm. 2 (february 2021) , p. 450-457  
6.
1 p, 118.3 KB Correction to : Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey / Lebwohl, Mark (Icahn School of Medicine at Mount Sinai) ; Langley, Richard G. (Dalhousie University) ; Paul, Carle (Paul Sabatier University) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Reich, Kristian (University Medical Center Hamburg-Eppendorfi) ; van de Kerkhof, Peter (Radboud University Medical Center) ; Wu, Hsiuan-Lin (Amgen Inc) ; Richter, Sven (Amgen Inc) ; Jardon, Shauna (Amgen Inc) ; Gisondi, Paolo (University Hospital of Verona (Itàlia)) ; Universitat Autònoma de Barcelona
2022 - 10.1007/s13555-021-00656-z
Dermatology and Therapy, Vol. 12 (january 2022) , p. 79  
7.
16 p, 894.7 KB Evolution of Patient Perceptions of Psoriatic Disease : Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey / Lebwohl, Mark (Icahn School of Medicine at Mount Sinai) ; Langley, Richard G. (Dalhousie University) ; Paul, Carle (Paul Sabatier University) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Reich, Kristian (University Medical Center Hamburg-Eppendorf) ; van de Kerkhof, Peter (Radboud University Medical Center) ; Wu, Hsiuan-Lin (Amgen Inc) ; Richter, Sven (Amgen Inc) ; Jardon, Shauna (Amgen Inc) ; Gisondi, Paolo (University Hospital of Verona (Itàlia)) ; Universitat Autònoma de Barcelona
Since the 2012 Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey, several systemic treatments for psoriasis (PsO) and/or psoriatic arthritis (PsA) have been approved. The population-based UPLIFT survey was conducted to understand how perceptions of treatment-related outcomes have evolved, particularly for patients with mild to moderate PsO and/or PsA and their dermatologists. [...]
2021 - 10.1007/s13555-021-00635-4
Dermatology and Therapy, october 2021, p. 1-16  
8.
8 p, 669.5 KB Enodicalix (Diploporita, Aristocystitidae) : a new echinoderm genus from the Middle Ordovician of Spain / Paul, C. R. C. (University of Bristol. School of Earth Sciences) ; Gutiérrez-Marco, Juan Carlos (Centro Superior de Investigaciones Científicas. Instituto de Geociencias)
Restudy of an Ordovician diploporite specimen from the Middle Ordovician of central Spain reveals that the species 'Calix'inornatusMeléndez has four ambulacra, each with two equal facets, an oval hydropore and a smooth thecal surface. [...]
2020 - 10.1344/GeologicaActa2020.18.3
Geologica acta, Vol. 18 (2020) , p. 1-8 (Articles)  
9.
18 p, 504.6 KB Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis : Results from Greater Than 17,000 Patient-Years of Exposure / Armstrong, April W (Keck School of Medicine of the University of Southern California. Department of Clinical Research) ; Paul, Carle (Paul Sabatier University. Dermatology Department, Toulouse University Hospital (CHU)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Boehncke, Wolf-Henning (University of Geneva. Department of Pathology and Immunology) ; Freeman, Michael (The Skin Centre, Benowa, QLD Australia) ; Torii, Hideshi (Tokyo Yamate Medical Center. Division of Dermatology) ; Papp, Kim (K Papp Clinical Research and Probity Medical Research) ; Griffiths, Christopher E. M. (NIHR Manchester Biomedical Research Centre. Dermatology Centre, Salford Royal Hospital, University of Manchester) ; Blauvelt, Andrew (Oregon Medical Research Center) ; Reich, Kristian (Skinflammation® Center, Hamburg, Germany) ; Gooderham, Melinda (Centre for Dermatology and Probity Medical Research, Peterborough, ON Canada) ; Terui, Tadashi (Nihon University School of Medicine. Department of Dermatology) ; Renda, Lisa (Eli Lilly and Company) ; Agada, Noah (Eli Lilly and Company) ; Xu, Wen (Eli Lilly and Company) ; Gallo, Gaia (Eli Lilly and Company) ; Lebwohl, Mark G. (Icahn School of Medicine at Mount Sinai. Department of Dermatology) ; Universitat Autònoma de Barcelona
Long-term safety data are critical for evaluating therapies for psoriasis. Ixekizumab has demonstrated efficacy and is well tolerated for the treatment of moderate-to-severe plaque psoriasis. We examined the safety and tolerability of up to 5 years of ixekizumab therapy in patients with psoriasis. [...]
2019 - 10.1007/s13555-019-00340-3
Dermatology and Therapy, Vol. 10 (november 2019) , p. 133-150  
10.
10 p, 285.5 KB Pimecrolimus in atopic dermatitis : Consensus on safety and the need to allow use in infants / Luger, Thomas (University of Münster. Department of Dermatology) ; Boguniewicz, Mark (Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine) ; Carr, Warner (Southern California Research) ; Cork, Michael (Academic Unit of Dermatology Research, Department of Infection and Immunity, The University of Sheffield, K Floor, The Medical School (RHH Tower)) ; Deleuran, Mette (Aarhus University Hospital (Aarhus, Dinamarca)) ; Eichenfield, Lawrence (Departments of Pediatrics and Medicine, University of California, San Diego School of Medicine, Rady Children's Hospital) ; Eigenmann, Philippe (Pediatric Allergy Unit, Children's University Hospital) ; Fölster-Holst, Regina (Department of Dermatology, University Clinics of Schleswig-Holstein) ; Gelmetti, Carlo (Department of Pathophysiology and Transplantation, University of Milan, Clinica Dermatologica, Fondazione I.R.C.C.S. Ca' Granda "Ospedale Maggiore Policlinico") ; Gollnick, Harald (Department of Dermatology & Venereology, Otto-von-Guericke University of Magdeburg) ; Hamelmann, Eckard (Allergy Center Ruhr, Ruhr-University Bochum, & Evangelisches Krankenhaus Bielefeld, Klinik für Kinder und Jugendmedizin) ; Hebert, Adelaide A. (Departments of Dermatology and Pediatrics, The University of Texas Medical School-Houston) ; Muraro, Antonella (Food Allergy Referral Centre, Department of Woman and Child Health, University Hospital of Padua) ; Oranje, Arnold P. (Intermedica Dermatology and Hair Clinic) ; Paller, Amy S. (Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine) ; Paul, Carle (Dermatology Department, INSERM 1056, Paul Sabatier University, Larrey Hospital) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Ring, Johannes (Technische Universität München) ; Siegfried, Elaine (Departments of Pediatrics and Dermatology, Saint Louis University School of Medicine) ; Spergel, Jonathan M. (Children's Hospital of Philadelphia (Pennsilvània)) ; Stingl, Georg (Department of Dermatology, Medical University of Vienna) ; Taieb, Alain (Service de Dermatologie et Dermatologie Pédiatrique Centre de référence pour les maladies rares de la peau, INSERM 1035, Université de Bordeaux) ; Torrelo, Antonio (Hospital Infantil Universitario Niño Jesús (Madrid)) ; Werfel, Thomas (Department of Dermatology and Allergy, Hannover Medical School) ; Wahn, Ulrich (Department of Pediatric Pneumology and Immunology, Charite) ; Universitat Autònoma de Barcelona
Atopic dermatitis (AD) is a distressing dermatological disease, which is highly prevalent during infancy, can persist into later life and requires long-term management with anti-inflammatory compounds. [...]
2015 - 10.1111/pai.12331
Pediatric Allergy and Immunology, Vol. 26 (april 2015) , p. 306-315  

Vea también: autores con nombres similares
1 Paul, C. R. C.
5 Paul, Carle
1 Paul, Carle F.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.